Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Asian Registry of the BioFreedom™ BA9™ Drug-Coated Coronary Stent for Patients With ST Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI)

NCT03609346 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.

NCT NCT03609346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03609346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Asian Registry of the BioFreedom™ BA9™ Drug-Coated Coronary Stent for Patients With ST Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI)
Lead sponsor
Biosensors Europe SA
Phase
Observational
Overall status
Completed
Start date
November 22, 2018
Completion date
August 5, 2022
Enrollment
914 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

stemi - st elevation myocardial infarction